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Effect of Non-Linear Elasticity of Skeletal Myosins on Force Generation
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During muscle force generation, an elastic energy stored at the compliant re-
gion of myosin head is a source of mechanical work against the external envi-
ronment. Thus, this elastic distortion of myosin molecule was modeled as an
essential mechanical element of the force generation driven by the crossbridges
(Huxley, 1957). In the crossbridge model, the central assumption of the con-
stant stiffness implies that the negatively-strained myosins must be detached
at much higher rate than the positively-strained myosins to avoid the significant
drag effect. However, the molecular studies on processive motors, such as ki-
nesin and unconventional myosins, show that the assemblies of these motors do
not seem to impede the molecular interactions, although they have much higher
duty ratio and thus, a higher chance to cause the molecular interference. Re-
cently, we found that skeletal myosins have the non-linear elasticity, in which
stiffness is much higher when they are positively-strained and lower when
negatively-strained. Therefore, this non-linear elasticity seems to be the essen-
tial and complementary property of motors to avoid the drag force generation in
the motor assembly. We have currently worked on the theoretical model to in-
vestigate the effect of non-linear elasticity on the force generation, particularly
the force-velocity relationships and the T1-T2 curves obtained from the muscle
fiber quick release experiment.
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Cytoplasmic dynein is a motor protein that exerts force on microtubules and in
doing so, drives a myriad of intracellular activities from mitotic spindle posi-
tioning to chromosome movements in meiotic prophase. To exert force on mi-
crotubules, dynein needs anchorage, which is typically found at the cell
cortex. The key question is how dynein finds the sites where a microtubule
and an anchor protein are close enough for dynein to link them and subse-
quently pull on the microtubule. Here we directly observe single dyneins in
fission yeast and show that they attach in two steps, first from the cytoplasm
to a microtubule and then also to cortical anchors. Upon attachment to the mi-
crotubule, dynein moves in a diffusive manner along the microtubule. This is
a surprising finding for a minus end directed motor and may help dynein to
find cortical anchors. Our work demonstrates that dynein performs three-
dimensional diffusion in the cytoplasm and one-dimensional diffusion along
the microtubule to find sites where it can exert pulling force on the
microtubule.
26-Subg
Half-Site Inhibition of Kinesin-1 by a Single Tail Domain, Sometimes One
is Enough
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Isolated kinesin-1 is autoinhibited through binding of a region in the C-termi-
nal tail domain to the N-terminal head (motor) domains. Although the heavy
chain dimer has two head and two tail domains, the stoichiometry of binding
when expressed separately in trans is one tail peptide per two heads. Both mo-
nomeric and dimeric tail domain constructs have similar affinity for a dimer of
heads, indicating that the second peptide in a tail dimer does not contribute
significant additional free energy to the interaction. The recent solution of
the X-ray structure (Kaan et al., Science 333, 883 (2011)) of a complex of
one tail domain and a dimer of heads suggested a ‘double lockdown’ mecha-
nism in which ADP release is likely inhibited because the coupled undocking
of the neck linker cannot occur while maintaining both the cross link between
heads at the coiled coil neck and the new cross link provided by the tail do-
main that bridges two heads. This result stimulates a number of new questions
that will be addressed. If only one tail is interacting strongly with the heads,
what is the other tail peptide doing? Can it bind to cargo or regulators while
the other peptide remains bound to the heads? One approach is to produce
heterodimer tails with mutations that allow only one peptide to bind to
heads, while introducing probes into the other tail to test for its binding inter-
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Myosin V as a Point-to-Point Organelle Transporter
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Mice that lack myosin Va (dilute mice) exhibit two striking phenotypes-
a dilution of coat color and severe ataxia. Regarding the first phenotype, we
previously demonstrated that the myosin cooperates with long-range,
bidirectional, microtubule-based transport to position melanosomes at the
melanocyte’s dentritic tips, the site of melanosome transfer from the melano-
cyte to the keratinocyte (the Cooperative-Capture Model) (J. Cell Biol. 1998,
143:1899). These and other results have contributed to the current debate as
to whether type V myosins in higher eukaryotes function as vesicle transporters
or as dynamic vesicle tethers. Regarding the second phenotype, we have now
demonstrated that myosin Va serves as a point-to-point transporter to carry
the ER into the dendritic spines of cerebellar Purkinje neurons following its
long-range transport out dendrites via microtubule motors (Nature Cell Biol.
2011, 13:40). That the myosin actually moves the ER in vivo is supported by
several results, the most convincing of which is that in dilute Purkinje neurons
rescued with slow versions of myosin Va (lever arm truncations, a switch 1 mu-
tant), the speed of ER tubule transport into spines is slowed correspondingly.
Moreover, we show that this myosin Va-dependent ER targeting is required
for the local calcium transient downstream of strong spine activation that un-
derlies synaptic plasticity/learning and, hence, normal coordination. These re-
sults, together with another recent study from our lab demonstrating that the
Dictyostelium type V myosin MyoJ drives the cortical translocation of contrac-
tile vacuole membrane tubules (J. Cell Biol. 2009, 186:555), argue that, as in
yeast, type V myosins in higher eukaryotes can serve as point-to-point organ-
elle transporters.
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There is a large gap between the conditions we use to study molecular
motors in vitro, and the motor walking in a cellular environment. For simplic-
ity, in vitro experiments on myosin V generally use single constitutively
active truncated motor constructs that walk on individual bare actin filaments.
Within the cell, however, actin generally has bound tropomyosin. Full-length
motors are regulated by a folded-to-extended conformational transition, and
adapter proteins that link the motor to cargo can affect this conformational
transition. Adapter proteins, or the cargo itself, can also recruit multiple motors
to improve the efficiency of cargo movement. The theme of this talk is that
by re-creating a more native myosin complex and actin track, unexpected
properties of the motor emerge that are likely to be important for cellular cargo
transport. Several different class V myosins will be used to illustrate these
principles.
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Drug and Gene Delivery with ‘‘Smart’’ Nanoparticles and Live Cell
Imaging
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Highly sensitive fluorescence techniques, such as single molecule and single
particle tracking are used to follow the uptake and trafficking of nanoparticles
in living cells. Due to the high temporal and spatial resolution of the particle
trajectories, recorded in real time, mechanistic details of these processes are
revealed. Nanoparticles consisting of DNA complexed by cationic polymers
(polyplexes) and functionalized with cell-specific ligands for targeting are
investigated[1]. Furthermore, mesoporous silica nanoparticles[2] are observed,
which contain the drug inside the porous network of nanometer-sized channels
and show triggered release upon e.g. cell signalling[3].
In all these applications live cell imaging is used to understand the mechanistic
processes of uptake, trafficking and interactions of the nanoparticles with cell
components in order to improve the efficiencies of the nanoparticles as drug-
delivery systems.
[1] K. de Bruin et al., Mol. Therapy, 15 (2007), 1297; K. de Bruin et al., J.
Contr. Release, 130 (2008), 175; A. Sauer et al., J. Contr. Release, 137
(2009), 136; F.M. Ko¨nig et al., J. Contr. Release, (2011), accepted.
